To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06667908
Title A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) (CONVERGE)
Acronym CONVERGE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johnson & Johnson Enterprise Innovation Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Connecticut Health Center RECRUITING Farmington Connecticut 06030 United States Details
Orlando Health Cancer Institute RECRUITING Orlando Florida 32806 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
University of North Carolina at Chapel Hill RECRUITING Chapel Hill North Carolina 27514 United States Details
FirstHealth of the Carolinas RECRUITING Pinehurst North Carolina 28374 United States Details
University of Pennsylvania RECRUITING Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field